One of CLLS next targets. From a layman perspective it looks positive, and I'd assume they will apply for Orphan Drug status (if and when) they begin clinical trials in the US.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.